Samsung Impex Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 22-06-2024
- Paid Up Capital ₹ 2.21 Cr
as on 22-06-2024
- Company Age 28 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 9.95 Cr
as on 22-06-2024
- Revenue %
(FY 2020)
- Profit -98.21%
(FY 2020)
- Ebitda -144.61%
(FY 2020)
- Net Worth -1.03%
(FY 2020)
- Total Assets 58.94%
(FY 2020)
About Samsung Impex
The Corporate was formerly known as Samsung Pharmaceuticals Private Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.21 Cr.
The company has closed loans amounting to ₹9.95 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Supriya Satija and Saumaya Satija serve as directors at the Company.
- CIN/LLPIN
U24239DL1996PTC083057
- Company No.
083057
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Central Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Samsung Impex?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Supriya Satija  | Director | 04-Dec-2009 | Current |
| Saumaya Satija | Director | 16-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Samsung Impex.
Samsung Impex Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 98.21% decrease in profit. The company's net worth dipped by a decrease of 1.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samsung Impex?
In 2020, Samsung Impex had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vijay Global Private LimitedActive 25 years 1 monthSupriya Satija and Saumaya Satija are mutual person
- Yamasua Hind Private LimitedActive 3 years 8 months
Supriya Satija and Saumaya Satija are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Oriental Bank Of Commerce Creation Date: 18 Dec 2010 | ₹9.95 Cr | Satisfied |
How Many Employees Work at Samsung Impex?
Unlock and access historical data on people associated with Samsung Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samsung Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samsung Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
